- Home
- AIFC vs FBIO Comparison
AIFC vs FBIO Comparison
Compare AIFC & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AIFC | FBIO |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.4M | 90.7M |
| IPO Year | 1994 | 2011 |
Fundamental Metrics
Financial Performance| Metric | AIFC | FBIO |
|---|---|---|
| Price | $0.52 | $2.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | ★ 877.5K | 510.7K |
| Earning Date | N/A | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.40 |
| EPS | N/A | ★ 2.86 |
| Revenue | $12,532,000.00 | ★ $63,262,000.00 |
| Revenue This Year | N/A | $55.22 |
| Revenue Next Year | N/A | $40.55 |
| P/E Ratio | ★ N/A | $0.95 |
| Revenue Growth | N/A | ★ 9.69 |
| 52 Week Low | $0.36 | $2.18 |
| 52 Week High | $0.72 | $4.53 |
Technical Indicators
Market Signals| Indicator | AIFC | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 46.47 | 38.40 |
| Support Level | $0.38 | $2.55 |
| Resistance Level | $0.63 | $3.02 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 7.10 | 3.79 |
Price Performance
Historical ComparisonAbout AIFC AI Financial Corporation Common Stock
AI Financial Corp is a payment infrastructure company. The company provides payment infrastructure services focused on payment processing and financial transaction technologies. Its capabilities include payment processing, security features, tokenization, and AI-based commerce solutions. It also provides infrastructure for crypto and decentralized finance (DeFi) payment processing and is developing additional capabilities for automated and programmable payment systems.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.